ReviewJournal of pharmacy & bioallied sciences

Vorapaxar: A novel agent to be considered in the secondary prevention of myocardial infarction.

Obamiro Kehinde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.